Book a meeting with Genomics
Explore how our PRS solutions support healthcare and life sciences teams.
Get in touch
Detect more coronary artery disease risk with PRS
Combine genetics and clinical data to identify risk earlier and guide prevention.
Get the full white paper
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality worldwide, imposing a substantial clinical and economic burden. Identifying individuals at highest risk and treating them early is key to reducing this impact.
What you’ll learn
Our white paper, Integrating Polygenic Risk Scores with Familial Hypercholesterolemia for Enhanced CAD Prevention, explores:
- The population-level impact and risk equivalence between polygenic risk and FH
- Insights from the literature on enhanced therapeutic response in high-PRS individuals
- Practical integration of PRS into cardiovascular risk assessment and prevention